Frontiers in Microbiology,
Год журнала:
2021,
Номер
12
Опубликована: Сен. 28, 2021
Hypertension
is
a
significant
risk
factor
for
cardiovascular
and
cerebrovascular
diseases,
its
development
involves
multiple
mechanisms.
Gut
microbiota
has
been
reported
to
be
closely
linked
hypertension.
Short-chain
fatty
acids
(SCFAs)—the
metabolites
of
gut
microbiota—participate
in
hypertension
through
various
pathways,
including
specific
receptors,
immune
system,
autonomic
nervous
metabolic
regulation
gene
transcription.
This
article
reviews
the
possible
mechanisms
SCFAs
regulating
blood
pressure
prospects
as
target
prevent
treat
Nutrients,
Год журнала:
2023,
Номер
15(9), С. 2211 - 2211
Опубликована: Май 6, 2023
Short-chain
fatty
acids
(SCFAs)
play
a
key
role
in
health
and
disease,
as
they
regulate
gut
homeostasis
their
deficiency
is
involved
the
pathogenesis
of
several
disorders,
including
inflammatory
bowel
diseases,
colorectal
cancer,
cardiometabolic
disorders.
SCFAs
are
metabolites
specific
bacterial
taxa
human
microbiota,
production
influenced
by
foods
or
food
supplements,
mainly
prebiotics,
direct
fostering
these
taxa.
This
Review
provides
an
overview
SCFAs’
roles
functions,
SCFA-producing
bacteria,
from
microbiological
characteristics
taxonomy
to
biochemical
process
that
lead
release
SCFAs.
Moreover,
we
will
describe
potential
therapeutic
approaches
boost
levels
treat
different
related
diseases.
Nutrients,
Год журнала:
2021,
Номер
13(11), С. 4144 - 4144
Опубликована: Ноя. 19, 2021
Plant-based
diets,
defined
here
as
including
both
vegan
and
lacto-ovo-vegetarian
are
growing
in
popularity
throughout
the
Western
world
for
various
reasons,
concerns
human
health
of
planet.
diets
more
environmentally
sustainable
than
meat-based
have
a
reduced
environmental
impact,
producing
lower
levels
greenhouse
gas
emissions.
Dietary
guidelines
normally
formulated
to
enhance
society,
reduce
risk
chronic
diseases,
prevent
nutritional
deficiencies.
We
reviewed
scientific
data
on
plant-based
summarize
their
preventative
therapeutic
role
cardiovascular
disease,
cancer,
diabetes,
obesity,
osteoporosis.
Consuming
is
safe
effective
all
stages
life
cycle,
from
pregnancy
lactation,
childhood,
old
age.
which
high
fiber
polyphenolics,
also
associated
with
diverse
gut
microbiota,
metabolites
that
anti-inflammatory
functions
may
help
manage
disease
processes.
Concerns
about
adequate
intake
number
nutrients,
vitamin
B12,
calcium,
D,
iron,
zinc,
omega-3
fats,
discussed.
The
use
fortified
foods
and/or
supplements
well
appropriate
food
choices
outlined
each
nutrient.
Finally,
suggested
professionals
working
clients
consuming
diets.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Май 25, 2023
Abstract
Obstructive
sleep
apnea
syndrome
(OSAS)
is
a
common
breathing
disorder
in
which
the
airways
narrow
or
collapse
during
sleep,
causing
obstructive
apnea.
The
prevalence
of
OSAS
continues
to
rise
worldwide,
particularly
middle-aged
and
elderly
individuals.
mechanism
upper
airway
incompletely
understood
but
associated
with
several
factors,
including
obesity,
craniofacial
changes,
altered
muscle
function
airway,
pharyngeal
neuropathy,
fluid
shifts
neck.
main
characteristics
are
recurrent
pauses
respiration,
lead
intermittent
hypoxia
(IH)
hypercapnia,
accompanied
by
blood
oxygen
desaturation
arousal
sharply
increases
risk
diseases.
This
paper
first
briefly
describes
epidemiology,
incidence,
pathophysiological
mechanisms
OSAS.
Next,
alterations
relevant
signaling
pathways
induced
IH
systematically
reviewed
discussed.
For
example,
can
induce
gut
microbiota
(GM)
dysbiosis,
impair
intestinal
barrier,
alter
metabolites.
These
ultimately
secondary
oxidative
stress,
systemic
inflammation,
sympathetic
activation.
We
then
summarize
effects
on
disease
pathogenesis,
cardiocerebrovascular
disorders,
neurological
metabolic
diseases,
cancer,
reproductive
COVID-19.
Finally,
different
therapeutic
strategies
for
caused
causes
proposed.
Multidisciplinary
approaches
shared
decision-making
necessary
successful
treatment
future,
more
randomized
controlled
trials
needed
further
evaluation
define
what
treatments
best
specific
patients.
Nutrients,
Год журнала:
2022,
Номер
14(6), С. 1137 - 1137
Опубликована: Март 8, 2022
Growing
evidence
supports
the
hypothesis
that
dietary
factors
may
play
a
role
in
systemic
low-grade
chronic
inflammation.
Summary
from
randomized
controlled
trials
has
shown
substantial
effects
on
biomarkers
of
inflammation
following
adoption
plant-based
diets
(including,
but
not
limited
to,
Mediterranean
diet),
while
consistent
findings
have
been
reported
for
higher
intakes
whole
grains,
fruits,
and
vegetables
positive
trends
observed
consumption
legumes,
pulses,
nuts,
olive
oil.
Among
animal
food
groups,
dairy
products
to
best
benefits
inflammation,
red
meat
egg
neutral
effects.
The
present
review
provides
an
overview
mechanisms
underlying
relation
between
immune
system,
with
focus
specific
macronutrient
non-nutrient
phytochemicals
(polyphenols)
Substantial
differences
within
each
group
explain
conflicting
results
obtained
regarding
foods
high
saturated
fats
carbohydrates,
subtypes
molecules
(i.e.,
short-chain
fatty
acids
or
fiber
vs.
long
chain
free
added
sugars)
when
exploring
diet
as
well
importance
matrix
commixture
context
patterns.
Dietary
polyphenols
oligopeptides
hypothesized
exert
several
functions,
including
regulation
inflammatory
response
system.
Overall,
suggests
affect
system
regardless
obesity-related
Abstract
Background
Antimicrobials
are
often
used
to
prevent
and
treat
diarrhea
induced
by
enteroaggregative
Escherichia
coli
(EAEC)
in
young
ruminants.
However,
drug
overuse
or
misuse
accelerates
the
spread
of
multidrug-resistant
extended-spectrum
β-lactamase
(ESBL)-producing
E.
.
Thus,
supplementary
foods
as
alternatives
antibiotics
needed
colibacillus
neonatal
dairy
calves.
Ursodeoxycholic
acid
(UDCA),
a
therapeutic
bile
acid,
helps
alleviate
colitis.
how
UDCA
ESBL-EAEC-induced
clinical
symptoms
colitis
remains
unclear.
Results
We
investigated
microbial
profiles
metabolites
healthy
diarrheic
calves
determine
metabolite
biomarkers
early-life
development.
Both
gut
microbiota
communities
their
associated
differed
between
Commensal
Butyricicoccus
,
Faecalibacterium
Ruminococcus
Collinsella
Coriobacterium
were
key
markers
that
distinguished
microbiomes.
Random
forest
machine-learning
algorithm
Spearman
correlation
results
indicated
enriched
UDCA,
short-chain
fatty
acids
(SCFAs),
other
prebiotics
strongly
positively
correlated
with
these
five
bacterial
genera.
explored
effect
ursodiol
on
growth,
cell
adherence,
lipopolysaccharide-treated
Caco-2
cells.
Adding
direct
antibacterial
effects,
suppressed
proinflammatory
reduced
integrity
damage.
Oral
delivery
mice
exhibited
significant
effects
helped
maintain
colonic
barrier
mouse
models
peritonitis
sepsis
oral
infection.
supplementation
attenuated
recovered
SCFA
production.
To
validate
this,
we
performed
fecal
transplantations
inoculate
ESBL-EAEC-infected
mice.
Microbiotas
from
UDCA-treated
ameliorated
hindgut
commensal
damage
compared
microbiotas
control
placebo
mice,
evidenced
colonization
abundant
bacteria,
including
Oscillospiraceae,
Ruminococcaceae,
Lachnospiraceae,
Clostridia_UCG-014
upregulated
Conclusions
This
study
provided
first
evidence
could
confer
resistance
newborn
blocked
growth
invasion
both
vitro
vivo,
alleviated
dysbiosis
during
ESBL-EAEC
infection
via
TGR5-NF-κB
axis,
production
digesta.
Our
findings
provide
insight
into
UDCA-mediated
remission
infections
potential
role
an
antibiotic
alternative.
Journal of Agricultural and Food Chemistry,
Год журнала:
2022,
Номер
70(3), С. 711 - 735
Опубликована: Янв. 4, 2022
Owing
to
their
minimal
side
effects
and
effective
protection
from
oxidative
stress,
inflammation,
malignant
growth,
natural
polysaccharides
(NPs)
are
a
potential
adjuvant
therapy
for
several
diseases
caused
by
intestinal
barrier
injury
(IBI).
More
studies
accumulating
on
the
protective
of
NPs
with
respect
IBI,
but
underlying
mechanisms
remain
unclear.
Thus,
this
review
aims
represent
current
that
investigate
IBI
directly
maintaining
epithelial
integrity
(inhibiting
regulating
inflammatory
cytokine
expression,
increasing
tight
junction
protein
expression)
indirectly
immunity
microbiota.
Furthermore,
development
briefly
introduced,
structure–activity
relationships
discussed.
Potential
developments
challenges
associated
exhibiting
against
have
also
been
highlighted
guide
application
in
treatment
IBI.
Summary
Evidence
is
increasing
that
disturbances
in
the
gut
microbiome
may
play
a
significant
role
etiology
of
obesity
and
type
2
diabetes.
The
short
chain
fatty
acid
butyrate,
major
end
product
bacterial
fermentation
indigestible
carbohydrates,
reputed
to
have
anti‐inflammatory
properties
positive
effects
on
body
weight
control
insulin
sensitivity.
However,
whether
butyrate
has
therapeutic
potential
for
treatment
prevention
obesity‐related
complications
remains
be
elucidated.
Overall,
animal
studies
strongly
indicate
administered
via
various
routes
(e.g.,
orally)
positively
affects
adipose
tissue
metabolism
functioning,
energy
substrate
metabolism,
systemic
tissue‐specific
inflammation,
sensitivity
control.
A
limited
number
human
demonstrated
interindividual
differences
clinical
effectiveness
suggesting
outcomes
depend
metabolic,
microbial,
lifestyle‐related
characteristics
target
population.
Hence,
despite
abundant
evidence
from
data,
support
data
urgently
required
implementation
evidence‐based
oral
gut‐derived
interventions.
To
increase
efficacy
butyrate‐focused
interventions,
future
research
should
investigate
which
factors
impact
including
baseline
microbial
activity
functionality,
thereby
optimizing
targeted‐interventions
identifying
individuals
merit
most
such
American Journal of Respiratory and Critical Care Medicine,
Год журнала:
2023,
Номер
207(9), С. 1145 - 1160
Опубликована: Март 8, 2023
Epidemiological
studies
indicate
that
chronic
obstructive
pulmonary
disease
(COPD)
is
associated
with
the
incidence
of
changes
in
intestinal
health.
Cigarette
smoking,
as
one
major
causes
COPD,
can
have
an
impact
on
gastrointestinal
system
and
promotes
diseases.
This
points
to
existence
gut–lung
interactions,
but
overview
underlying
mechanisms
bidirectional
connection
between
lungs
gut
COPD
lacking.
The
interaction
occur
through
circulating
inflammatory
cells
mediators.
Moreover,
microbiota
dysbiosis,
observed
both
disorders,
lead
a
disturbed
mucosal
environment,
including
barrier
immune
system,
hence
may
negatively
affect
lungs.
Furthermore,
systemic
hypoxia
oxidative
stress
also
be
involved
dysfunction
play
role
axis.
In
this
review,
we
summarize
data
from
clinical
research,
animal
models,
vitro
explain
possible
interactions
COPD.
Interesting
observations
possibility
promising
future
add-on
therapies
for
patients
are
highlighted.